Octagon Capital Advisors »

Bioage Labs shares owned by Octagon Capital Advisors

Quarter-by-quarter ownership of Bioage Labs (BIOA) shares owned by Octagon Capital Advisors from 13F filings

Historical chart of Octagon Capital Advisors investment in Bioage Labs

Tip: Access up to 7 years of quarterly data

All positions including Bioage Labs held by Octagon Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bioage Labs by Octagon Capital Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $21M 1.6M 13.23

More positions owned by Octagon Capital Advisors

Abivax Sa Sponsored Ads (ABVX)
Dianthus Therapeutics (DNTH)
Cogent Biosciences (COGT)
Taysha Gene Therapies Com Shs (TSHA)
Gossamer Bio (GOSS)
Kymera Therapeutics (KYMR)
Arrivent Biopharma (AVBP)
Trevi Therapeutics (TRVI)
Ocular Therapeutix (OCUL)
Mind Medicine Mindmed Com New (MNMD)
Cg Oncology Call Option (CGON)
Alumis (ALMS)
Palisade Bio (PALI)
Cidara Therapeutics Com New (CDTX)
Bioage Labs (BIOA)

View all positions for Octagon Capital Advisors

Top funds holding Bioage Labs

AH Capital Management
Sofinnova Ventures
Cormorant Asset Management
Octagon Capital Advisors
Vanguard Group
BlackRock
OrbiMed Advisors
Sands Capital Ventures
Pivotal bioVenture Partners Investment Advisor
Geode Capital Management
Cosmic Management
State Street Corporation
Redpoint Management
Siren
Jacobs Levy Equity Management

View all funds holding Bioage Labs